Randal Scott

Dr. Randal W.
Scott is an Independent Director at Freenome, Inc., a Chairman & Chief Executive Officer at Genomic Life, Inc., a Chairman at Genome Medical, Inc. and an Independent Director at Talis Biomedical Corp.
He is on the Board of Directors at Freenome, Inc. and Talis Biomedical Corp.
Dr. Scott was previously employed as an Independent Director by BridgeBio Pharma, Inc., a Chairman by Invitae Corp., an Executive Chairman by Invitae Corp., an Executive Chairman by Genomic Health, Inc., and a President by Incyte Pharmaceuticals, Inc. He also served on the board at Freenome Holdings, Inc. and Station X, Inc. He received his undergraduate degree from Emporia State University and a doctorate degree from the University of Kansas.